| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |